Cargando…

The Role of Lipid-Lowering Treatment in the Secondary Prevention of Ischemic Stroke

Dyslipidemia is a major modifiable risk factor for ischemic stroke. Treatment with statins reduces the incidence of recurrent ischemic stroke and also reduces coronary events in patients with a history of ischemic stroke. Therefore, statins represent an important component of secondary prevention of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsankof, Alexandra, Tziomalos, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788422/ https://www.ncbi.nlm.nih.gov/pubmed/35076490 http://dx.doi.org/10.3390/diseases10010003

Ejemplares similares

Adiponectin: A player in the pathogenesis of hormone-dependent cancers
por: Tsankof, Alexandra, et al.
Publicado: (2022)

Effects of glucose-lowering agents on ischemic stroke
por: Avgerinos, Konstantinos, et al.
Publicado: (2017)

Considerations for management of patients with diabetes mellitus and acute COVID-19
por: Mougakou, Efterpi, et al.
Publicado: (2022)

Role of lipid-lowering agents in the management of diabetic retinopathy
por: Ioannidou, Estelle, et al.
Publicado: (2017)

Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?
por: Tsankof, Alexandra, et al.
Publicado: (2022)

Homocysteine Reduction for Stroke Prevention: Regarding the Recent AHA/ASA 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
por: Brown, Craig, et al.
Publicado: (2023)

Associations between nonalcoholic fatty liver disease and ischemic stroke
por: Alkagiet, Stelina, et al.
Publicado: (2018)

Discussing the Score of Cardioembolic Ischemic Stroke in Chagas Disease
por: Mendes, Fernanda de Souza Nogueira Sardinha, et al.
Publicado: (2020)

Ancient Chinese Herbal Recipe Huanglian Jie Du Decoction for Ischemic Stroke: An Overview of Current Evidence
por: Yu, Chao-Chao, et al.
Publicado: (2022)

Challenges in management and prevention of ischemic heart disease in low socioeconomic status people in LLMICs
por: Gupta, Rajeev, et al.
Publicado: (2019)

Incretin-Based Antihyperglycemic Agents for the Management of Acute Ischemic Stroke in Patients with Diabetes Mellitus: A Review
por: Milonas, Dimitrios, et al.
Publicado: (2019)

Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target
por: Hoenig, Michel R
Publicado: (2008)

A new paradigm for primary prevention strategy in people with elevated risk of stroke
por: Feigin, Valery L, et al.
Publicado: (2014)

Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions
por: Kalus, James S
Publicado: (2013)

Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review
por: Tziomalos, Konstantinos, et al.
Publicado: (2006)

Acute Secondary Prevention of Ischemic Stroke: Overlooked No Longer
por: Bulwa, Zachary B., et al.
Publicado: (2021)

Personalized approach to primary and secondary prevention of ischemic stroke
por: Polívka, Jiří, et al.
Publicado: (2014)

Effective Preventative Measures are Essential to Lower Disease Burden From Dengue and COVID-19 Co-infection in Bangladesh
por: Das, Proma Rani, et al.
Publicado: (2023)

Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas
por: Briand, Valérie, et al.
Publicado: (2007)

Malnutrition in Patients with Acute Stroke
por: Bouziana, Stella D., et al.
Publicado: (2011)

Platelet aggregation inhibitors in primary and secondary prevention of ischemic stroke
por: Gorenoi, Vitali, et al.
Publicado: (2006)

Current Surgical Treatment for Neurogenic Lower Urinary Tract Dysfunction in Patients with Chronic Spinal Cord Injury
por: Fan, Yu-Hua, et al.
Publicado: (2023)

Effects of an Avocado-based Mediterranean Diet on Serum Lipids for Secondary Prevention after Ischemic Stroke Trial (ADD-SPISE): Study protocol
por: Olavarría, Verónica V., et al.
Publicado: (2021)

Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa?
por: Gaillard, Tiphaine, et al.
Publicado: (2018)

Medical foods for lowering homocysteine in hypertensive patients
por: Elias, Merrill F., et al.
Publicado: (2022)

Epidemiology and Risk Factors for Stroke in Chronic Kidney Disease: A Narrative Review
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke
por: Nakase, Taizen, et al.
Publicado: (2015)

Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
por: Michaeli, Daniel Tobias, et al.
Publicado: (2023)

Treatment of renal lower pole stones: an update
por: Mazzucchi, Eduardo, et al.
Publicado: (2021)

Bioactive Lipids in COVID-19-Further Evidence
por: Das, Undurti N.
Publicado: (2021)

Hypothesized neuroprotective effect of minocycline against COVID-19-induced stroke and neurological dysfunction: possible role of matrix metalloprotease signaling pathway
por: Aghajani Shahrivar, Ali, et al.
Publicado: (2022)

LDL-C: lower is better for longer—even at low risk
por: Penson, Peter E., et al.
Publicado: (2020)

Is a healthy microbiome responsible for lower mortality in COVID-19?
por: Janda, Lubomír, et al.
Publicado: (2020)

TSH lowering effects of metformin: a possible mechanism of action
por: Cannarella, R., et al.
Publicado: (2020)

Secondary Stroke Prevention After Ischemic Stroke in Patients with Alzheimer’s Disease and Other Dementia Disorders
por: Zupanic, Eva, et al.
Publicado: (2020)

Nasal therapy—The missing link in optimising strategies to improve prevention and treatment of COVID-19
por: Ratcliffe, Norman A., et al.
Publicado: (2021)

Therapeutic Carbohydrate Restriction as a Metabolic Modality for the Prevention and Treatment of Abnormal Uterine Bleeding
por: Salcedo, Andrea C., et al.
Publicado: (2023)

Brain gene therapy with Trojan horse lipid nanoparticles
por: Pardridge, William M.
Publicado: (2023)

Cancer prevention in patients with human immunodeficiency virus infection
por: Valanikas, Evripidis, et al.
Publicado: (2018)

Contributions of Lower Structures to Higher Cognition: Towards a Dynamic Network Model
por: Saban, William, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gns3fq9mth3a43r0a612ssm5f4